Showing results (21-30 of 94) with videos related to

Sort By:
Pageof 10
Clinical Pharmacokinetics|October 11, 2016
Disease-Drug Interaction of Sarilumab and Simvastatin in Patients with Rheumatoid ArthritisEun Bong Lee, Nikki Daskalakis, Christine Xu, et al.
Clinical Rheumatology|August 31, 2018
Determination of the minimally important difference (MID) in multi-biomarker disease activity (MBDA) test scores: impact of diurnal and daily biomarker variation patterns on MBDA scoresDavid Chernoff, P Scott Eastman, Ching Chang Hwang, et al.
Clinical Therapeutics|January 27, 2009
Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adultsAlan Kivitz, Michael Fairfax, Eric A Sheldon, et al.
Arthritis Research & Therapy|March 30, 2019
An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritisStanley Cohen, Jose L Pablos, Karel Pavelka, et al.
RMD Open|February 14, 2018
Secukinumab provides sustained improvements in the signs and symptoms of active ankylosing spondylitis with high retention rate: 3-year results from the phase III trial, MEASURE 2Helena Marzo-Ortega, Joachim Sieper, Alan Kivitz, et al.
International Journal of Clinical Practice|October 9, 2021
Gender, age, disease severity, body mass index and diabetes may not affect response to subcutaneous tanezumab in patients with osteoarthritis after 16 weeks of treatment. A subgroup analysis of placebo-controlled trialsFrancis Berenbaum, Thomas Schnitzer, Alan Kivitz, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 29, 2015
A Randomized Trial Comparing Disease Activity Measures for the Assessment and Prediction of Response in Rheumatoid Arthritis Patients Initiating Certolizumab PegolJeffrey R Curtis, Melvin Churchill, Alan Kivitz, et al.
Rheumatology International|November 13, 2021
Nonsteroidal anti-inflammatory drug-sparing effect of secukinumab in patients with radiographic axial spondyloarthritis: 4-year results from the MEASURE 2, 3 and 4 phase III trialsMaxime Dougados, Uta Kiltz, Alan Kivitz, et al.
RMD Open|March 5, 2022
Evaluation of response to 13-valent conjugated pneumococcal vaccination in patients with rheumatoid arthritis receiving upadacitinib: results from a phase 2 open-label extension studyKevin Winthrop, Juan Ignacio Vargas, Edit Drescher, et al.
Clinical Therapeutics|September 18, 2024
The Totality of Evidence for SDZ-deno: A Biosimilar to Reference DenosumabBarbara Vogg, Johann Poetzl, Arnd Schwebig, et al.
Pageof 10